Equity Incentive Plan (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2019 Plan
	Nine Months Ended September 30, 2023		Nine Months Ended September 30, 2022
Total fair value of stock options granted	$	941	$	2,898
Total fair value of options vested		1,784		944

Schedule of Black Scholes model for the Private Warrants

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employee directors under the 2019 Plan:

	Nine Months Ended September 30, 2023			Nine Months Ended September 30, 2022
Expected volatility		41.2	%	42.78% - 42.90	%
Expected term (in years)		6.00		6.00
Dividend yield		0.00	%	0.00	%
Risk-free interest rate		3.61	%	1.62% - 2.71	%

Stock Based Compensation Expense Included In Condensed Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Company’s Condensed Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	Three Months Ended September 30, 2023		Three Months Ended September 30, 2022		Nine Months Ended September 30, 2023		Nine Months Ended September 30, 2022
Cost of revenues	$	228	$	396	$	699	$	1,158
General and administrative		422		556		1,319		1,475
Research and development		103		159		273		396
Sales and marketing		88		185		260		626
Total	$	841	$	1,296	$	2,551	$	3,655

Restricted Stock Units [Member]

Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity for performance based RSUs awarded to employees and for time-based RSUs granted to non-employee directors under the 2019 Plan:

Description	RSUs Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)
RSUs non-vested, December 31, 2022		1,876,669		$	6.45		6.10
Granted		788,120			2.03		—
Vested		(190,059	)		6.52		—
Forfeited		(27,642	)		6.44		—
Expired		—			—		—
RSUs non-vested, September 30, 2023		2,447,088		$	5.99		5.78

2019 Plan [Member]

Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Options outstanding, December 31, 2022		5,757,779		$	7.92		7.60
Granted		990,296			1.05			$	1,330,150
Exercised		—			—
Forfeited		(25,190	)		5.58
Expired		(160,942	)		8.08
Options outstanding, September 30, 2023		6,561,943		$	9.88		7.33	$	1,330,150
Options vested and exercisable, September 30, 2023		4,509,168		$	8.22		6.67	$	—
Options vested and expected to vest, September 30, 2023		6,561,943		$	9.88		7.33	$	1,330,150

_______________________________

(1)Aggregate intrinsic value (in thousands) represents the difference between the estimated fair value of the underlying Common Stock and the exercise price of outstanding in-the-money options.